相关实验视频
Updated: Jul 6, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
关于高血症管理的共识文件
Alberto Ortiz1, Carmen Del Arco Galán2, José Carlos Fernández-García3
1Sociedad Española de Nefrología (S.E.N.), Spain.
Nefrologia
|January 3, 2024
概括
超血,一种常见的电解质失衡,对健康构成重大风险. 这份共识文件提供了一种统一的,最新的方法来管理高血症,包括新的药物治疗方法.
科学领域:
- 内部医学 内部医学
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學.
- 紧急医疗 紧急医疗
背景情况:
- 高血是普遍存在的电解质障碍,具有严重的健康影响.
- 管理是分散在各个专业,需要一个统一的方法.
- 新药疗法需要更新临床指南.
研究的目的:
- 审查平衡和高血的基本方面.
- 概述概念,流行病学,病理生理学和诊断策略.
- 为高血症管理提供最新的治疗建议.
主要方法:
- 由西班牙领先的科学协会制定的共识文件.
- 对现有证据和已发表的研究进行全面审查.
- 专注于患者护理的多学科方法.
主要成果:
- 提供了对平衡的基本理解.
- 详细介绍高血的临床表现和潜在机制.
- 提供有关当前诊断和治疗干预措施的指导.
结论:
- 强调需要对高血症采取标准化,多学科的方法.
- 强调更新管理策略的重要性.
- 旨在作为临床医生管理高血症的实用工具.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
569
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
569
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Regulation of Sodium and Potassium
541
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
541
Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K

